Medtronic Announces New Kyphoplasty Platform
This article was originally published in The Gray Sheet
Executive Summary
The firm says the new system will give physicians more options to treat patients with a varying severity of spinal injury.
You may also be interested in...
Medtronic Goes Trolling? Kyphon Patents Are Basis Of New Suits, But Not From Medtronic
Recently incorporated Orthophoenix, which shares the same Dallas address as IPNav, a company that provides “full-service patent monetization,” is suing six device firms for infringement of the Medtronic kyphoplasty patents it recently acquired.
Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal
Medtronic is aiming to expand the breadth of its spinal offerings and, in particular, reach a relatively untapped older patient population with its $3.9 billion acquisition of Kyphon, announced July 27 (see chart: "1Medtronic-Kyphon Deal Basics")
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”